Register
Get access to our best features
Subscribe
Spotlight Growth image

Spotlight Growth

Information about Spotlight GrowthWhere is Spotlight Growth located?Spotlight Growth's Website

Factuality

How credible is the news from Spotlight Growth?
Unknown
by Ad Fontes Media and Media Bias/Fact Check
Learn more about Factuality Ratings.

Media Bias Ratings

Does Spotlight Growth lean left or right?
Learn more about Media Bias Ratings.

Top Spotlight Growth News

C3.ai leaps on launch of new AI-focused product suite, ChatGPT integration
Artificial Intelligence

C3.ai leaps on launch of new AI-focused product suite, ChatGPT integration

100% Center coverage: 1 sources
C3.ai (AI) shares gained nearly 28% in early trading on Tuesday. The company announced it was introducing a new artificial intelligence focused product suite. The new suite, known as C3 Generative AI Product Suite, uses natural language to "rapidly locate, retrieve, and present all relevant data"See the Story
Versus Systems to Partner with Resolve to Bring Generative AI and Gamification to Customer Payments and Credit Management

Versus Systems to Partner with Resolve to Bring Generative AI and Gamification to Customer Payments and Credit Management

Versus Systems Inc. will partner with automated debt collection and artificial intelligence company Resolve Debt Inc. to bring gamification and interactive elements to Resolve's existing AI-powered credit and debt management products and customers. The goal is to address a portion of the $4.5 trillion US consumer (non-mortgage) debt market. This unique partnership will incorporate AI and gamification to provide a cutting-edge user experience.See the Story
Elys Acquires Software Engineering and IT Development Firm Engage IT Services, S.r.l.

Elys Acquires Software Engineering and IT Development Firm Engage IT Services, S.r.l.

Elys Game Technology, Corp. has completed the acquisition of a premium software engineering and IT development firm, Engage IT Services, S.r.l. The firm offers best-in-class development of sportsbook and gaming applications for cloud, web, and mobile platforms. Engage has also provided contract services to Elys, playing a key role in the development of our Elys Gameboard technology.See the Story

Latest News Stories

Mullen Automotive receives $200 million purchase order for 6,000 EV cargo vans

100% Center coverage: 1 sources
Mullen Automotive has landed a $200 million purchase order to manufacture 6,000 Class 1 electric-powered cargo vans. Mullen recently purchased the Mishawaka auto assembly plant where the commercial Hummer was once made. Work on the cargo van contract will take place at a plant in Tunica, Miss.See the Story

Indivior PLC to Acquire Opiant Pharmaceuticals - Opiant Pharma (NASDAQ:OPNT)

100% Center coverage: 3 sources
Indivior (OTCPK:INVVY) is acquiring opioid overdose therapy maker Opiant Pharmaceuticals (NASDAQ:OPNT) for ~$145M. Indivior will acquire all outstanding shares of Opiant for an upfront $20 per share in cash. Opiant contributed to the development of the formulation of Narcan Nasal Spray.See the Story

Maxar Technologies acquired by private equity firm in $6.4 billion deal

Coverage: 2 sources
Advent International, based in Boston, Massachusetts, is a global firm with $89 billion in assets. Advent is acquiring all outstanding shares of Maxar common stock for $53.00 per share in cash. Maxar, with an estimated $2 billion in revenue for 2022, will remain a U.S.-controlled company.See the Story

Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery

Palisade Bio, Inc. (Nasdaq: PALI) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery. LB11 48, is a broad-spectrum serine protease inhibitor which acts to neutralize digestive enzymes, potentially reducing intestinal damage.See the Story

Boston Scientific to buy Apollo Endosurgery for $417 million

100% Center coverage: 1 sources
Boston Scientific Corporation (BSX.N) said on Tuesday it will buy medical technology firm Apollo Endosurgery Inc (APEN.O) for $417 million. Its shares were up 63% in premarket trading. With debt, the deal is valued at about $615 million.See the Story

Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

100% Center coverage: 1 sources
The modern-day world is full of stories and stories, but one of the most famous is the story of a young boy and his family's journey through the woods to find out what it is like to live in a shack in the woods. The story of the young boy, his family, and the woods around them is filled with stories, stories, and memories of his childhood. The boy's family, who used to live on a farm in rural New Hampshire, is now living in the town of Wabasha, where they used to call it the "Yin and Yang" The boy, who was born on the farm, is the son of a farmer, and his mother is the daughter of a doctor.See the Story
FDA

Kala Pharmaceuticals stock rockets after FDA accepts IND application for PCED treatment

Coverage: 2 sources
Shares of Kala Pharmaceuticals Inc. KALA, +1.03% shot up 45.7% in premarket trading Wednesday. The company said the Food and Drug Administration accepted its investigational new drug (IND) application for KPI-012, its treatment of persistent corneal epithelial defect (PCED)See the Story

Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge - Viatris (NASDAQ:VTRS)

100% Center coverage: 1 sources
Viatris will commence a tender offer for $11.00 per share in cash at closing. Oyster Point Pharma launched Tyrvaya, the first and only FDA-approved nasal spray for the signs and symptoms of dry eye disease. The transaction is anticipated to close during the first quarter of 2023.See the Story

Breaking News Topics Related to Spotlight Growth

Stock MarketsStock Markets
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogSubscribeGiftCareersFor Educators/Libraries
HelpHelp CenterFAQMedia Bias RatingsOwnership and Factuality RatingsInterestsContact UsReferral Code
ToolsBrowser ExtensionRehashMediaopolyTwitter BlindspotterDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyTerms and Conditions
© 2023 Snapwise Inc.
News
Feed
SearchBlindspotLocal